---
schema_version: "secwatch.filing_event.v1"
accession: "0001428336-23-000012"
form_type: "8-K"
ticker: "HQY"
cik: "0001428336"
company_name: "HEALTHEQUITY, INC."
filed_at: "2023-03-21T23:59:59+00:00"
generated_at: "2026-06-17T22:09:34.964168+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HealthEquity FY2023 revenue $861.7M (+14% YoY); guides FY2024 rev $960-975M, EBITDA $320-335M

## Summary
- Q4 revenue $233.8M (+15% YoY); net loss $0.2M vs $32.8M loss; non-GAAP EPS $0.37 vs $0.20.
- FY2023 Adjusted EBITDA $272.3M (+15% YoY); margin 32% vs 31%.
- HSAs grew 11% to 8.0M; total HSA assets $22.1B (+13%).
- FY2024 guidance: revenue $960-975M, non-GAAP EPS $1.74-$1.87, Adjusted EBITDA $320-335M.
- Record new HSA sales and highest ever accounts & assets; became largest HSA custodian.

## SEC filing metadata
- accession: 0001428336-23-000012
- form_type: 8-K
- ticker: HQY
- cik: 0001428336
- company_name: HEALTHEQUITY, INC.
- filed_at: 2023-03-21T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000012/0001428336-23-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000012/hqy-20230321.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001428336-23-000012
- JSON: https://secwatch.observer/filing/0001428336-23-000012.json
- Plain text: https://secwatch.observer/filing/0001428336-23-000012.txt

## Key facts
- Earnings Releases
  HEALTHEQUITY, INC. reported the fiscal year ended January 31, 2023 results: revenue $861.7 million, net income Net loss of $26.1 million, EPS $0.31 per diluted share.
  - Period: the fiscal year ended January 31, 2023
  - Revenue: $861.7 million
  - Net income: Net loss of $26.1 million
  - EPS: $0.31 per diluted share
  - Result: reported results
  source text: Revenue for the fiscal year ended January 31, 2023 was $861.7 million, an increase of 14% compared to $756.6 million for the fiscal year ended January 31, 2022. Revenue this year included: service revenue of $430.2 million, custodial revenue of $283.1 million, and interchange revenue of $148.4 million. HealthEquity reported a net loss of $26.1 million, or $0.31 per diluted share, and non-GAAP net income of $114.5 million, or $1.36 per diluted share, for the fiscal year ended January 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000012/0001428336-23-000012-index.htm
- Earnings Releases
  HEALTHEQUITY, INC. reported the fourth quarter ended January 31, 2023 results: revenue $233.8 million, net income Net loss of $0.2 million, EPS less than one cent per diluted share.
  - Period: the fourth quarter ended January 31, 2023
  - Revenue: $233.8 million
  - Net income: Net loss of $0.2 million
  - EPS: less than one cent per diluted share
  - Result: reported results
  source text: Revenue for the fourth quarter ended January 31, 2023 was $233.8 million, an increase of 15% compared to $203.3 million for the fourth quarter ended January 31, 2022. Revenue this quarter included: service revenue of $114.2 million, custodial revenue of $83.5 million, and interchange revenue of $36.1 million. HealthEquity reported a net loss of $0.2 million, or less than one cent per diluted share, and non-GAAP net income of $31.3 million, or $0.37 per diluted share, for the fourth quarter ended January 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000012/0001428336-23-000012-index.htm
- Earnings Releases
  HEALTHEQUITY, INC. reported the fiscal year ending January 31, 2024 results: revenue $960 million to $975 million, net income between $0 and $11 million, EPS $0.00 to $0.13 per diluted share. Guidance initiated.
  - Period: the fiscal year ending January 31, 2024
  - Revenue: $960 million to $975 million
  - Net income: between $0 and $11 million
  - EPS: $0.00 to $0.13 per diluted share
  - Guidance: initiated
  - Result: guidance update
  source text: For the fiscal year ending January 31, 2024, management expects revenues of $960 million to $975 million. Its outlook for net income is between $0 and $11 million, resulting in net income of $0.00 to $0.13 per diluted share. Its outlook for non-GAAP net income, calculated using the method described below, is between $152 million and $163 million, resulting in non-GAAP net income per diluted share of $1.74 to $1.87 (based on an estimated 87 million weighted-average shares outstanding).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000012/0001428336-23-000012-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.